McCormick & Co (NYSE: MKC) shares are trading higher on Friday.
UBS upgraded the stock from Neutral to Buy and raised its price target from $151 to $160.
McKesson is the largest and most complex of the leading third-party logistics providers. The company is engaged in wholesale pharmaceutical and medical products sourcing, distribution and dispensing, contract manufacturing, and related IT services to acute care hospitals and health systems, independent and chain retail pharmacies in North America, Europe, and Canada.
McCormick shares were trading up 1.86% at $178.77 on Friday. The stock has a 52-week high of $178.98 and a 52-week low of $112.22.